C G Kruse Selected Research

SLV 330

5/2010

SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C G Kruse Research Topics

Disease

3	Cognitive Dysfunction 01/2016 - 05/2010
3	Schizophrenia (Dementia Praecox) 01/2006 - 01/2000
2	Alzheimer Disease (Alzheimer's Disease) 09/2011 - 05/2010
2	Memory Disorders (Memory Loss) 09/2011 - 05/2010
1	Substance-Related Disorders (Drug Abuse) 01/2013
1	Herpes Zoster 01/2006
1	Neurodevelopmental Disorders 11/2001
1	Parkinson Disease (Parkinson's Disease) 01/2000
1	Nervous System Diseases (Neurological Disorders) 01/2000

Drug/Important Bio-Agent (IBA)

3	serotonin 6 receptorIBA 01/2016 - 09/2011
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2011 - 05/2010
2	Scopolamine (Hyoscine)FDA Link 09/2011 - 05/2010
2	Donepezil (Aricept)FDA LinkGeneric 09/2011 - 05/2010
1	Cytidine Monophosphate (CMP)IBA 09/2011
1	SLV 330IBA 05/2010
1	Nicotine FDA Link 05/2010
1	N-Methylaspartate (NMDA)IBA 05/2010
1	Dizocilpine Maleate (Dizocilpine)IBA 05/2010
1	Muscarinic AntagonistsIBA 05/2010
1	Serotonin (5 Hydroxytryptamine)IBA 01/2006
1	Potassium Channels (Potassium Channel)IBA 01/2006
1	Dopamine (Intropin)FDA LinkGeneric 01/2006
1	GTP-Binding Proteins (G-Protein)IBA 01/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2001
1	NeurotensinIBA 01/2000